Formula Optimization of Fast Disintegrating Tablet (FDT) of Centella asiatica (L.) Urb. Ethanolic Extract

  • Agatha Budi Susiana Lestari UNIVERSITAS SANATA DHARMA
  • Achmad Fudholi UNIVERSITAS GADJAH MADA
  • Akhmad Kharis Nugroho UNIVERSITAS GADJAH MADA
  • Erna Prawita Setyowati UNIVERSITAS GADJAH MADA
DOI: https://doi.org/10.35814/jifi.v16i1.423

Abstract

It has been proven that Centella asiatica (L.) Urb. herbs have an antioxidant activity that make it possible to used in preventing degenerative illness. Centella asiatica (L.) extract has been formulated to fast disintegrating tablet (FDT) dosage form. The aims of this study are to find the optimum formula of FDT of Centella asiatica (L.) Urb. The simplex lattice design method with 3 factors (which are mannitol as diluents, crospovidone as superdisintegrant and povidone as binder) and 2 levels of each was used. Centella asiatica (L.) Urb. extract was produce from maceration process using ethanol-water in ratio 75%:25% as a solvent. Direct compress method was used to produce the FDT. The results show that the optimum composition between excipients FDT formula could be reached, which fullfiled the physical properties parameter which are the hardness, friability and disintegration time of FDT.

References

1. Zheng, C. and Qin, L. Chemical components of Centella asiatica and their bioactivities, Journal of Chinese Integrative Medicine. 2007. 5(3), 348–351.

2. Brinkhaus, B., Lindner, M., Schuppan, D., and Hahn, E. G. Chemical, pharmacological and clinical profile of the East Asian medical plant Centella asiatica, Phytomedicine. 2000. 7(5):427–448.

3. Departemen Kesehatan Republik Indonesia. Farmakope Herbal Indonesia, edisi I, Jakarta, 2008. p 109-115, 171-175, 182-183.

4. Lestari, A, Fudholi A, Nugroho A, Setyowati E, Pengaruh Purifikasi n-Heksana pada Serbuk Simplisia terhadap Kadar Asiatikosida, Penangkapan Radikal Bebas dan Kadar Fenol Total Ekstrak Etanolik Herba Pegagan (Centella asiatica (L.) Urban), Jurnal Ilmu Kefarmasian Indonesia. 2015. 13(1), 10-16.

5. Chandrasekhar, R., Hassan, Z., AlHusban, F., Smith, A. M. and Mohammed, A. R. The role of formulation excipients in the development of lyophilised fast-disintegrating tablets. European Journal of Pharmaceutics and Biopharmaceutics. 2009. 72(1):119–129.

6. Katsuno, E., Tahara, K., Takeuchi, Y. and Takeuchi, H. Orally disintegrating tablets prepared by a co-processed mixture of micronized crospovidone and mannitol using a ball mill to improve compactibility and tablet stability, Powder Technology. 2013. 241:60–66.

7. Hirani, J. J., Rathod, D. A., and Vadalia, K. R. Orally Disintegrating Tablets: A Review, Tropical Journal of Pharmaceutical Research. 2009. 8(2):161–172

8. Hsu, A. F. dan Han, C. 2005, Oral disintegrating dosage forms, diakses pada 24 Februari 2017, http://www.freepatentsonline.com/y2005/0147670.html.

9. Velmurugan, S. and Vinushitha, S. Oral Disintegrating Tablets : An Overview, International Journal of Chemical and Pharmaceutical Scences. 2010. 1(II):1–12.
Published
2018-04-27
How to Cite
LESTARI, Agatha Budi Susiana et al. Formula Optimization of Fast Disintegrating Tablet (FDT) of Centella asiatica (L.) Urb. Ethanolic Extract. JURNAL ILMU KEFARMASIAN INDONESIA, [S.l.], v. 16, n. 1, p. 94-99, apr. 2018. ISSN 2614-6495. Available at: <http://jifi.farmasi.univpancasila.ac.id/index.php/jifi/article/view/423>. Date accessed: 25 apr. 2024. doi: https://doi.org/10.35814/jifi.v16i1.423.
Citation Formats
Issue
Vol 16 No 1 (2018): JIFI
Section
Articles
License

Licencing
All articles in Jurnal Ilmu Kefarmasian Indonesia are an open-access article, distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License which permits unrestricted non-commercial used, distribution and reproduction in any medium.

This licence applies to Author(s) and Public Reader means that the users mays :

  • SHARE:
    copy and redistribute the article in any medium or format
  • ADAPT:
    remix, transform, and build upon the article (eg.: to produce a new research work and, possibly, a new publication)
  • ALIKE:
    If you remix, transform, or build upon the article, you must distribute your contributions under the same license as the original.
  • NO ADDITIONAL RESTRICTIONS:
    You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.

It does however mean that when you use it you must:

  • ATTRIBUTION: You must give appropriate credit to both the Author(s) and the journal, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.

You may not:

  • NONCOMMERCIAL: You may not use the article for commercial purposes.

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.